カテゴリー： Grand View Research, 世界, 医療/バイオ

世界のヌクレオチド市場2023-2030：製品別（デオキシヌクレオチド）、技術別（TaqMan対立遺伝子識別、ジーンチップ＆マイクロアレイ）、用途別、地域別

◆英語タイトル：Nucleotide Market Size, Share & Trends Analysis Report By Product (Deoxy Nucleotides), By Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), By Application, By Region, And Segment Forecasts, 2023 - 2030

Grand View Researchが発行した調査報告書（GRV23NVB085）◆商品コード：GRV23NVB085
◆発行会社（リサーチ会社）：Grand View Research
◆発行日：2023年10月5日
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single UserUSD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算￥1,056,400見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

ヌクレオチド市場の成長と動向
Grand View Research社の最新レポートによると、世界のヌクレオチド市場規模は2023年から2030年にかけて7.12%のCAGRを記録し、2030年には13億7,725万米ドルに達する見込みです。世界のヌクレオチド市場は、医薬品や食品・飲料産業での広範な使用により、予測期間中に大幅な成長が見込まれています。診断研究と医薬品用途は、免疫力強化、腸への好影響、ストレスからの回復への好影響などの特性により、ヌクレオチド市場を支配しています。さらに、家畜栄養のための酵母由来のヌクレオチドと相まって、食物ヌクレオチド分野の研究開発が世界中で拡大しており、予測期間中の需要を促進する見込みです。

ヌクレオチド市場レポートハイライト

- TaqMan対立遺伝子識別セグメントが2022年の世界市場を支配、次いでパイロシーケンスによるSNPが続いています。

- 診断研究セグメントが2022年のヌクレオチド世界市場を支配しました。

- デオキシヌクレオチド（dNTPs）セグメントが2022年の世界ヌクレオチド市場を47.49%の収益シェアで支配し、さらに予測期間中に最速のCAGR 7.34%で拡大する見込みです。

- アジア太平洋地域は、2023年から2030年にかけてCAGR 7.81%で成長し、他地域の中で最速の成長が見込まれます。同地域には大手ヌクレオチドメーカーが存在し、栄養補助食品や健康食品業界の需要増と相まって、同製品の需要が増加する見通しです。さらに、特にアジア太平洋地域における食品・飲料添加物の探求の増加は、予測期間にわたってヌクレオチドの市場成長を促進する可能性が高いです。

第1章. 調査方法・範囲
第2章. エグゼクティブサマリー
第3章. ヌクレオチドの市場変数・傾向・範囲
第4章. ヌクレオチドの世界市場：製品別予測・傾向分析
第5章. ヌクレオチドの世界市場：技術別予測・傾向分析
第6章. ヌクレオチドの世界市場：用途別予測・傾向分析
第7章. ヌクレオチドの世界市場：地域別予測・傾向分析
第8章. 競争状況

❖ レポートの目次 ❖

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Technology
1.1.3. Application
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Technology outlook
2.2.3. Application outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Nucleotides Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Nucleotides Market Analysis Tools
3.4.1. Industry Analysis – Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
Chapter 4. Nucleotides Market: Product Estimates & Trend Analysis
4.1. Nucleotides Market: Key Takeaways
4.2. Nucleotides Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Deoxy Nucleotides
4.3.1. Deoxy Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.3.1.1. By production method
4.3.1.1.1. Enzyme sourced
4.3.1.1.2. Chemical synthesis
4.4. Dideoxynucleotides
4.4.1. Dideoxynucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Nucleotides for RNA Synthesis (rNTP)
4.5.1. Nucleotides for RNA Synthesis (rNTP) market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Labelled Nucleotides
4.6.1. Labelled Nucleotides market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Nucleotides Market: Technology Estimates & Trend Analysis
5.1. Nucleotides Market: Key Takeaways
5.2. Nucleotides Market: Technology Movement & Market Share Analysis, 2022 & 2030
5.3. TaqMan Allelic Discrimination
5.3.1. TaqMan allelic discrimination market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Gene Chips & microarrays
5.4.1. Gene chips & microarrays market estimates and forecasts, 2018 to 2030 (USD Million)
5.5. SNP by Pyrosequencing
5.5.1. SNP by pyrosequencing market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. Others
5.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Nucleotides Market: Application Estimates & Trend Analysis
6.1. Nucleotides Market: Key Takeaways
6.2. Nucleotides Market: Application Movement & Market Share Analysis, 2022 & 2030
6.3. Pharmaceuticals
6.3.1. Pharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Diagnostics Research
6.4.1. Diagnostics research market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Food & Beverage Additive
6.5.1. Food & beverage additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Animal Feed Additive
6.6.1. Animal feed additive market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Others
6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Nucleotides Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Nucleotides Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Market Participant Categorization
8.2.1. CJ CHEILJEDANG CORP
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Star Lake Bioscience Co., Inc.
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Thermo Fisher Scientific Inc.
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. MEIHUA HOLDINGS GROUP CO., LTD.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. F. Hoffmann-La Roche Ltd.
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. Biorigin
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic initiatives
8.2.7. DSM Nutritional Products AG
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Promega Corporation
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Agilent Technologies Inc.
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. Lallemand Inc.
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives
8.2.11. Nanjing Biotogether Co., Ltd.
8.2.11.1. Company overview
8.2.11.2. Financial performance
8.2.11.3. Product benchmarking
8.2.11.4. Strategic initiatives
8.2.12. NuEra Nutraceuticals Inc.
8.2.12.1. Company overview
8.2.12.2. Financial performance
8.2.12.3. Product benchmarking
8.2.12.4. Strategic initiatives
8.2.13. Ohly
8.2.13.1. Company overview
8.2.13.2. Financial performance
8.2.13.3. Product benchmarking
8.2.13.4. Strategic initiatives

List of Tables

Table 1 List of Abbreviations
Table 2 North America nucleotides market, by product, 2018 - 2030 (USD Million)
Table 3 North America nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 4 North America nucleotides market, by application, 2018 - 2030 (USD Million)
Table 5 North America nucleotides market, by region, 2018 - 2030 (USD Million)
Table 6 U.S. nucleotides market, by product, 2018 - 2030 (USD Million)
Table 7 U.S. nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. nucleotides market, by application, 2018 - 2030 (USD Million)
Table 9 Canada nucleotides market, by product, 2018 - 2030 (USD Million)
Table 10 Canada nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada nucleotides market, by application, 2018 - 2030 (USD Million)
Table 12 Europe nucleotides market, by product, 2018 - 2030 (USD Million)
Table 13 Europe nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 14 Europe nucleotides market, by application, 2018 - 2030 (USD Million)
Table 15 Europe nucleotides market, by region, 2018 - 2030 (USD Million)
Table 16 Germany nucleotides market, by product, 2018 - 2030 (USD Million)
Table 17 Germany nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany nucleotides market, by application, 2018 - 2030 (USD Million)
Table 19 UK nucleotides market, by product, 2018 - 2030 (USD Million)
Table 20 UK nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 21 UK nucleotides market, by application, 2018 - 2030 (USD Million)
Table 22 France nucleotides market, by product, 2018 - 2030 (USD Million)
Table 23 France nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 24 France nucleotides market, by application, 2018 - 2030 (USD Million)
Table 25 Italy nucleotides market, by product, 2018 - 2030 (USD Million)
Table 26 Italy nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy nucleotides market, by application, 2018 - 2030 (USD Million)
Table 28 Spain nucleotides market, by product, 2018 - 2030 (USD Million)
Table 29 Spain nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain nucleotides market, by application, 2018 - 2030 (USD Million)
Table 31 Denmark nucleotides market, by product, 2018 - 2030 (USD Million)
Table 32 Denmark nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark nucleotides market, by application, 2018 - 2030 (USD Million)
Table 34 Sweden nucleotides market, by product, 2018 - 2030 (USD Million)
Table 35 Sweden nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden nucleotides market, by application, 2018 - 2030 (USD Million)
Table 37 Norway nucleotides market, by product, 2018 - 2030 (USD Million)
Table 38 Norway nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 39 Norway nucleotides market, by application, 2018 - 2030 (USD Million)
Table 40 Asia Pacific nucleotides market, by product, 2018 - 2030 (USD Million)
Table 41 Asia Pacific nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 42 Asia Pacific nucleotides market, by application, 2018 - 2030 (USD Million)
Table 43 Asia Pacific nucleotides market, by region, 2018 - 2030 (USD Million)
Table 44 Japan nucleotides market, by product, 2018 - 2030 (USD Million)
Table 45 Japan nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 46 Japan nucleotides market, by application, 2018 - 2030 (USD Million)
Table 47 China nucleotides market, by product, 2018 - 2030 (USD Million)
Table 48 China nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 49 China nucleotides market, by application, 2018 - 2030 (USD Million)
Table 50 India nucleotides market, by product, 2018 - 2030 (USD Million)
Table 51 India nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 52 India nucleotides market, by application, 2018 - 2030 (USD Million)
Table 53 Australia nucleotides market, by product, 2018 - 2030 (USD Million)
Table 54 Australia nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 55 Australia nucleotides market, by application, 2018 - 2030 (USD Million)
Table 56 Thailand nucleotides market, by product, 2018 - 2030 (USD Million)
Table 57 Thailand nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 58 Thailand nucleotides market, by application, 2018 - 2030 (USD Million)
Table 59 South Korea nucleotides market, by product, 2018 - 2030 (USD Million)
Table 60 South Korea nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 61 South Korea nucleotides market, by application, 2018 - 2030 (USD Million)
Table 62 Latin America nucleotides market, by product, 2018 - 2030 (USD Million)
Table 63 Latin America nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 64 Latin America nucleotides market, by application, 2018 - 2030 (USD Million)
Table 65 Latin America nucleotides market, by region, 2018 - 2030 (USD Million)
Table 66 Brazil nucleotides market, by product, 2018 - 2030 (USD Million)
Table 67 Brazil nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil nucleotides market, by application, 2018 - 2030 (USD Million)
Table 69 Mexico nucleotides market, by product, 2018 - 2030 (USD Million)
Table 70 Mexico nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico nucleotides market, by application, 2018 - 2030 (USD Million)
Table 72 Argentina nucleotides market, by product, 2018 - 2030 (USD Million)
Table 73 Argentina nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina nucleotides market, by application, 2018 - 2030 (USD Million)
Table 75 Middle East and Africa nucleotides market, by product, 2018 - 2030 (USD Million)
Table 76 Middle East and Africa nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 77 Middle East and Africa nucleotides market, by application, 2018 - 2030 (USD Million)
Table 78 Middle East and Africa nucleotides market, by region, 2018 - 2030 (USD Million)
Table 79 South Africa nucleotides market, by product, 2018 - 2030 (USD Million)
Table 80 South Africa nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa nucleotides market, by application, 2018 - 2030 (USD Million)
Table 82 Saudi Arabia nucleotides market, by product, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia nucleotides market, by application, 2018 - 2030 (USD Million)
Table 85 UAE nucleotides market, by product, 2018 - 2030 (USD Million)
Table 86 UAE nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE nucleotides market, by application, 2018 - 2030 (USD Million)
Table 88 Kuwait nucleotides market, by product, 2018 - 2030 (USD Million)
Table 89 Kuwait nucleotides market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait nucleotides market, by application, 2018 - 2030 (USD Million)

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界のヌクレオチド市場2023-2030：製品別（デオキシヌクレオチド）、技術別（TaqMan対立遺伝子識別、ジーンチップ＆マイクロアレイ）、用途別、地域別(Nucleotide Market Size, Share & Trends Analysis Report By Product (Deoxy Nucleotides), By Technology (TaqMan Allelic Discrimination, Gene Chips & Microarrays), By Application, By Region, And Segment Forecasts, 2023 - 2030)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界の医療用チューブ市場2023-2030：シリコーン、ポリオレフィン、ポリ塩化ビニル、ポリカーボネート、その他
  • 世界のマイクロプリント市場2022-2030：市場規模、シェア、動向分析
  • 世界のコールドスプレー技術市場2023-2030：市場規模、シェア、動向分析
  • アテレクトミー装置の世界市場2023-2030：市場規模、シェア、動向分析
  • 生体吸収性冠動脈ステントの世界市場2023-2030：市場規模、シェア、動向分析

    • ◆H&Iグローバルリサーチのお客様（例）◆